ML329
ML329 is a micropthalmia-associated transcription factor (MITF) inhibitor, which inhibits TRPM-1 promoter activity with an IC50 of 1.2 μM.
Product Specifications
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ML329.html
Concentration
10mM
Purity
98.0
Solubility
DMF : 5 mg/mL (ultrasonic) |DMSO : 5 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(NC(C2=O)=CC(C3=C2C=CC=C3)=O)C=C1)(N)=O
Molecular Formula
C16H12N2O4S
Molecular Weight
328.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Faloon PW, et al. A Small Molecule Inhibitor of the MITF Molecular Pathway. Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD) : National Center for Biotechnology Information (US) ; 2010-2012 Dec 13.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-101464/ML329-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-101464/ML329-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[19992-50-8]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
36578141 1x10<sup>6</sup> cells/1.0ml
PHF5FP CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details GTR15312256 1 Vial
Lentiviral human MYL9 shRNA (UAS) - Lentiviral human MYL9 shRNA (UAS, RFP) plasmid
Ask
View Details